Quarterly report · Q3
4078.TEDINET S100Q2X8
Period2022-04-01 → 2022-12-31
Filed2023-02-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥63.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥80.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥59.6bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥6.0bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.7bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.5bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.0bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.5bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.3bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥5.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥131.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥123.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥123.6bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.6bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥41.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥82.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥81.1bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥207.79 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.31 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥315.69 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥126.84 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥808m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥808m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.7bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥58.1bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥57.5bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥575m |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥5.5bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.5bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥233m |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥394m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥64.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥63.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥808m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥5.9bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥1.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥1.5bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥54.1bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥53.4bn |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥765m |
| jpcrp040300-q3r_E00780-000Chemicalreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥7.1bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥6.5bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥258m |
| jpcrp040300-q3r_E00780-000Medicine And Health Carereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥454m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥60.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥59.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥1.0bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥7.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding trade notes receivable discounted or transferred by endorsement (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding insurance income and loss on disaster (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding details of extraordinary losses (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |